Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Methylation markers of malignant potential in meningiomas

9 Aug 2013

Abstract excerpt

OBJECT: Although most meningiomas are benign, about 20% are atypical (Grade II or III) and have increased mortality and morbidity. Identifying tumors with greater malignant potential can have significant clinical value. This validated genome-wide methylation study comparing Grade I with Grade II and III meningiomas aims to discover genes that are aberrantly methylated in atypical meningiomas. METHODS: Patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Meningioma and schwannoma management
Share to Neurofibromatosis and Schwannoma Cases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23930849
DOI: 10.3171/2013.7.jns13311

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Methylation markers of malignant potential in meningiomasPMID 23930849Read ↗

DNA methylation meningioma biomarkers: attributes and limitationsSemantic proximity Read ↗

DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups.Semantic proximity Read ↗

Molecular characteristics of meningiomasSemantic proximity Read ↗

A clinically applicable integrative molecular classification of meningiomas.Semantic proximity Read ↗

DNA Methylation in the Malignant Transformation of MeningiomasSemantic proximity Read ↗

Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomasSemantic proximity Read ↗

Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapiesSemantic proximity Read ↗

Meningioma Genomics: Diagnostic, Prognostic, and Therapeutic ApplicationsSemantic proximity Read ↗

Hypermitotic meningiomas harbor DNA methylation subgroups with distinct biological and clinical featuresSemantic proximity Read ↗

Clinical potential of meningioma genomic insights: a practical review for neurosurgeons.Semantic proximity Read ↗

Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomasSemantic proximity Read ↗

Molecular And Genetic Characterization Of Atypical And Anaplastic Meningioma’s Implications For Prognosis And Targeted TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.